(19)
(11) EP 1 204 868 A1

(12)

(43) Date of publication:
15.05.2002 Bulletin 2002/20

(21) Application number: 00955469.2

(22) Date of filing: 10.08.2000
(51) International Patent Classification (IPC)7G01N 33/574, G01N 33/68, A61K 38/17, A61K 48/00, A61K 31/7088, A61K 31/7084, A61K 31/4184, A61K 31/40, A61P 35/00
(86) International application number:
PCT/US0022/077
(87) International publication number:
WO 0111/369 (15.02.2001 Gazette 2001/07)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 10.08.1999 US 148091 P
10.08.1999 US 148092 P
17.09.1999 US 154616 P
06.12.1999 US 454495
06.12.1999 US 455300

(71) Applicant: Pangene Corporation
Fremont, CA 94538 (US)

(72) Inventors:
  • STURZBECHER, Horst-Werner
    D-23627 Gross Sarau (DE)
  • REDDY, Gurucharan
    Fremont, CA 94555 (US)

(74) Representative: Denison, Christopher Marcus et al
Mewburn EllisYork House23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) CANCER TREATMENTS AND DIAGNOSTICS UTILIZING RAD51 RELATED MOLECULES AND METHODS